Researchers have discovered the pharmacological drug, Naltrexone, significantly restored the function of faulty receptors associated with myalgic encephalomyelitis, also known as Chronic Fatigue Syndrome (ME/CFS).
Nov 11, 2019
0
837
Three days after testing positive for COVID-19, "everything tasted like cardboard," recalls 38-year-old Elizabeth Medina, who lost her sense of taste and smell at the start of the pandemic. A year later, she fears she will ...
Mar 28, 2021
0
28
Research at Brighton and Sussex Medical School (BSMS) has found that websites by cosmetic surgery providers offer incomplete information to perspective patients.
Sep 28, 2018
0
58
Today, HIV can be managed with medical treatment. However, despite 40 years of intensive research, scientists have not yet succeeded in finding a cure for the disease. People with HIV experience a flare-up of the virus only ...
Sep 18, 2023
1
46
Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig's disease, a potential setback for patient groups who have lobbied for the medication's approval.
Mar 31, 2022
0
2
In a small group of patients hospitalized with severe complications of COVID-19 and treated with the experimental antiviral drug remdesivir, clinical improvement was observed in 68% of patients treated, according to an analysis ...
Apr 13, 2020
0
4
An experimental treatment for urinary tract infections has easily passed its first test in animals, alleviating weeks-long infections in mice in as little as six hours.
Nov 16, 2011
0
0
In order for organisms to react swiftly to stimuli in their environment, they need rapid and precise transmission of nerve impulses along neural extensions known as axons. Whereas some invertebrates have developed very thick ...
Sep 18, 2020
0
61
Degenerating neurons in patients with Alzheimer's disease (AD) measurably responded to an experimental gene therapy in which nerve growth factor (NGF) was injected into their brains, report researchers at University of California, ...
Aug 27, 2015
0
30
A clinical trial led by the National Cancer Institute (NCI), part of the National Institutes of Health, has resulted in the first approval of a treatment for advanced alveolar soft part sarcoma (ASPS). The immunotherapy drug ...
Dec 28, 2022
0
44
